Misoprostol Before Caesarean Section
Misoprostol Administration Before Elective Caesarean Section to Reduce the Risk of Respiratory Morbidity in Newborns
Kafrelsheikh University
160 participants
Jun 1, 2024
INTERVENTIONAL
Conditions
Summary
The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.
Eligibility
Inclusion Criteria5
- Women with indication for elective caesarean section.
- Age less than 35 years old.
- Gestational age less than 38 weeks.
- Gestational age will be confirmed by certain LMP or reliable early ultrasound measurement of crown-rump length.
- Singleton pregnancy with no major anomalies
Exclusion Criteria4
- Any obstetric disorders as preeclampsia and diabetes.
- Fetus with oligohydramnios, intrauterine growth restriction.
- Any contraindications to misoprostol like those with previous allergic reaction or hypersensitivity to prostaglandin hemorrhagic disorders, and severe anemia.
- History of more than or equal 2 previous caesarean section.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
administration of 100mg of misoprostol to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06946914